(31) showed that ghrelin suppresses active GLP-1 secretion in STC-1 cells, whereas Gagnon et al
For first-time incretin users, tirzepatide offers several advantages: FDA approval, established safety data, pre-filled injection pens (no reconstitution needed), extensive prescriber experience, and lower side effect rates
Reduced waist circumference Better blood sugar control Lower blood pressure Improved cholesterol levels Greater energy and mobility These health gains often appear before major weight changes become visible
Getting a protein drug through the stomach without being digested was considered essentially impossible for most of the 20th century
However, well-designed human studies demonstrating such synergy are lacking
Most clinicians recommend stopping the medication at least two months before trying for a baby